GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Amyris Inc (OTCPK:AMRSQ) » Definitions » Beta

Amyris (Amyris) Beta : 8.47 (As of Apr. 28, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Amyris Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2024-04-28), Amyris's Beta is 8.47.


Amyris Beta Historical Data

The historical data trend for Amyris's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amyris Beta Chart

Amyris Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.08 2.38 1.50 1.25 0.73

Amyris Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.36 1.33 0.89 0.73 0.88

Competitive Comparison of Amyris's Beta

For the Specialty Chemicals subindustry, Amyris's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Amyris's Beta Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Amyris's Beta distribution charts can be found below:

* The bar in red indicates where Amyris's Beta falls into.



Amyris Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


Amyris  (OTCPK:AMRSQ) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Amyris Beta Related Terms

Thank you for viewing the detailed overview of Amyris's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.


Amyris (Amyris) Business Description

Traded in Other Exchanges
N/A
Address
5885 Hollis Street, Suite 100, Emeryville, CA, USA, 94608
Amyris Inc is an industrial biotechnology company. It is engaged in the engineering, manufacturing, and sales of products in a variety of consumer and industrial markets, including cosmetics, flavors and fragrances, solvents and cleaners, polymers, lubricants, healthcare products, and fuels. The business operations are spread across the world with the majority of the revenues generated in the United States. The company generates revenue from the sale of renewable products, licenses of and royalties from intellectual property, and grants, and collaborative research and development services.
Executives
J. Scott White director 100 ABBOTT PARK ROAD, ABBOTT PARK IL 60064
Philip J. Gund officer: Chief Restructuring Officer C/O SUNEDISON, INC., 13736 RIVERPORT DR., MARYLAND HEIGHTS MO 63043
M. Freddie Reiss director 2951 28TH STREET, SUITE 1000, SANTA MONICA CA 90405
Hermanus Kieftenbeld officer: Chief Financial Officer 259 PROSPECT PLAINS RD., BLDG A, CRANBURY NJ 08512
Eduardo Alvarez officer: Chief Operating Officer AMYRIS, INC., 5885 HOLLIS STREET, SUITE 100, EMERYVILLE CA 94608
Elizabeth E. Dreyer officer: CHIEF ACCOUNTING OFFICER EDGEWELL PERSONAL CARE, 1350 TIMBERLAKE MANOR PARKWAY, CHESTERFIELD MO 63017
Frank Kung director C/O VIVO CAPITAL, 505, PALO ALTO CA 94301
Nicole Kelsey officer: General Counsel and Secretary AMYRIS, INC., 5885 HOLLIS STREET, SUITE 100, EMERYVILLE CA 94608
John Melo director, officer: President and CEO C/O AMYRIS, INC., 5885 HOLLIS ST., SUITE 100, EMERYVILLE CA 94608
Anthony Hughes officer: Chief Accounting Officer 5885 HOLLIS STREET, SUITE 100, EMERYVILLE CA 94608
Ana Dutra director C/O KORN/FERRY INTERNATIONAL, 1900 AVENUE OF THE STARS, SUITE 2600, LOS ANGELES CA 90067
James F Mccann director ONE OLD COUNTRY ROAD, SUITE 500, CARLE PLACE NY 11514
Ryan Panchadsaram director 5885 HOLLIS ST., SUITE 100, EMERYVILLE CA 94608
L John Doerr director, 10 percent owner C/O KLEINER PERKINS CAUFIELD & BYERS, 2750 SAND HILL ROAD, MENLO PARK CA 94025
Julie Washington director C/O JAMBA, INC., 6475 CHRISTIE AVENUE, NO. 150, EMERYVILLE CA 94608